Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results

por Raab, Marc S., Zamagni, Elena, Manier, Salomon, Rodriguez‐Otero, Paula, Schjesvold, Fredrik, Broijl, Annemiek
Publicado 2023

Is immunotherapy here to stay in multiple myeloma?

por Rodríguez-Otero, Paula, Paiva, Bruno, Engelhardt, Monika, Prósper, Felipe, San Miguel, Jesús F.
Publicado 2017

CAR T-Cells in Multiple Myeloma Are Ready for Prime Time

por Rodríguez-Otero, Paula, Prósper, Felipe, Alfonso, Ana, Paiva, Bruno, Miguel, Jesús F. San
Publicado 2020

Assessment of hospital daily cleaning practices using ATP bioluminescence in a developing country

por Zambrano, Alejandra A., Jones, Alex, Otero, Paula, Ajenjo, Maria Cristina, Labarca, Jaime A.
Publicado 2014

International Academy of Health Sciences Informatics (IAHSI): Strategy and Focus Areas, 1st Version

por Martin-Sanchez, Fernando, Ball, Marion J., Kimura, Michio, Otero, Paula, Huesing, Elaine, Lehmann, Christoph U., Haux, Reinhold
Publicado 2020

Information and communication technologies in neonatal health

por Duran, Pablo, Sommer, Janine A, Otero, Paula, Daus, Mariana, Benitez, Sonia, Serruya, Suzanne, Francisco, Luis Andres De
Publicado 2020

P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM...

por Paiva, Bruno, Zherniakova, Anastasiia, Nuñez, Jorge, Rodríguez-Otero, Paula, Shi, Qian, Munshi, Nikhil, Durie, Brian, San Miguel, Jesús
Publicado 2023

Single-Institution Experience in Clinical Trials During the COVID-19 Pandemic in Spain: Not So Bad After All?

por Rodriguez-Otero, Paula, Reis, Joana, Alfonso-Pierola, Ana, Salas-Benito, Diego, Giraldez, Miriam, Azanza, Jose Ramón, Ponz-Sarvise, Mariano
Publicado 2020

The International Academy of Health Sciences Informatics (IAHSI): IMIAs Academy is Now Established and on Track

por Haux, Reinhold, Ball, Marion J., Kimura, Michio, Martin-Sanchez, Fernando, Otero, Paula, Huesing, Elaine, Koch, Sabine, Lehmann, Christoph U.
Publicado 2020

The International Academy of Health Sciences Informatics (IAHSI): 2020 Report

por Haux, Reinhold, Ball, Marion J., Hersh, William R., Huesing, Elaine, Kimura, Michio, Koch, Sabine, Martin-Sanchez, Fernando, Otero, Paula
Publicado 2021

CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil

por Hungria, Vania, Piérola, Ana Alfonso, Filho, Jayr Schmidt, Crusoe, Edvan, Filho, Roberto José Pessoa de Magalhães, Maiolino, Angelo, Rodríguez-Otero, Paula
Publicado 2023

P908: IDENTIFICATION OF CYTOKINES ASSOCIATED WITH RESPONSE AND CYTOKINE RELEASE SYNDROME – ANALYSIS OF MAGNETISMM-3 COHORT A

por Weisel, Katja, Bahlis, Nizar J, Rodríguez-Otero, Paula, Viqueira, Andrea, Wang, Shen-Wu, Sathiah, Sangeetha, Robinson, Douglas, O’brien, Thomas, Quach, Hang
Publicado 2023

P906: GENOMIC ANALYSIS TO IDENTIFY DETERMINANTS OF INHERENT RESPONSE AND RESISTANCE TO ELRANATAMAB IN MAGNETISMM-3 COHORT A

por Rodríguez-Otero, Paula, Quach, Hang, Weisel, Katja, Viqueira, Andrea, Wang, Shen-Wu, Hamilton, Phineas T., Xie, Tao, O’brien, Thomas, Bahlis, Nizar J
Publicado 2023

The International Academy of Health Sciences Informatics: 2021 Update

por Hersh, William R., Haux, Reinhold, Huesing, Elaine, Ball, Marion J., Kimura, Michio, Otero, Paula, Detmer, Don, Koch, Sabine, Saranto, Kaija K., Wright, Graham
Publicado 2022

P946: TOCILIZUMAB PRE-TREATMENT SIGNIFICANTLY REDUCES THE INCIDENCE OF CYTOKINE RELEASE SYNDROME IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE CEVOSTAMAB

por Mateos, Maria-Victoria, Bahlis, Nizar J, Spencer, Andrew, Kaedbey, Rayan, Rodríguez-Otero, Paula, Harrison, Simon, Wong, Chihunt, Goodman, Grant, Nakamura, Rin, Choeurng, Voleak, Cooper, James, Trudel, Suzanne
Publicado 2023

Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients

por Ocio, Enrique M., Bringhen, Sara, Martinez-Lopez, Joaquin, San-Miguel, Jesus, Oliva, Stefania, Rodriguez-Otero, Paula, Le Roux, Nadia, Dong, Yvonne, Doroumian, Severine, Macé, Sandrine, Mateos, Maria-Victoria
Publicado 2023

MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations

por San José-Enériz, Edurne, Román-Gómez, José, Jiménez-Velasco, Antonio, Garate, Leire, Martin, Vanesa, Cordeu, Lucia, Vilas-Zornoza, Amaia, Rodríguez-Otero, Paula, José Calasanz, María, Prósper, Felipe, Agirre, Xabier
Publicado 2009

PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACT...

por Lonial, Sagar, Quach, Hang, Dimopoulos, Meletios A., Rodríguez-Otero, Paula, Berdeja, Jesus, Richardson, Paul, Kyada, Margee, Chu, Shuyu, Chen, Min, Abad, Patricia, Morando, Juliane, van de Donk, Niels W.C.J.
Publicado 2023

PB2133: TRIAL IN PROGRESS: LINKER-MM3, A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF LINVOSELTAMAB VERSUS ELOTUZUMAB, POMALIDOMIDE, AND DEXAMETHASONE (EPD) IN RELAPSED/REFRACTORY MULT...

por Weisel, Katja, Hungria, Vania, Quach, Hang, Yoon, Sung-Soo, Rodríguez-Otero, Paula, Kroog, Glenn, Sinha, Arijit, Boyapati, Anita, Lyon, Charlotte, Lorenc, Karen Rodriguez, Inocencio, Timothy, Harnett, James, Chi, Lei, Moore, Vygngley, Voorhees, Peter
Publicado 2023

(11)C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions

por Lapa, Constantin, Garcia-Velloso, Maria J., Lückerath, Katharina, Samnick, Samuel, Schreder, Martin, Otero, Paula Rodriguez, Schmid, Jan-Stefan, Herrmann, Ken, Knop, Stefan, Buck, Andreas K., Einsele, Hermann, San-Miguel, Jesus, Kortüm, Klaus Martin
Publicado 2017